ANVS Annovis Bio Inc Total Business Assets
The stable management of Annovis Bio, Inc. (ANVS) is focused on the successful completion of neurological drug trials. This chart of the company's price action demonstrates total assets at 21.74. The business relies on synergy with medical centers in the study of dementia and tremors, while the development strategy is based on a green chemistry approach and strict adherence to ethical standards when working with biomaterials.
Analytical breakdowns and data insights for company Annovis Bio Corp (ANVS)
- current quotes and average value forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Annovis Bio, Inc.|ANVS - Long-Term Debt to Equity|Current Liabilities to Capital Annovis Bio Corporation|ANVS - Company Aggregate Debts|Debts to Book Capitalization Annovis Bio Corporation|ANVS - Company Long-Term Debt|Company Short-Term Indebtedness Annovis Bio|Immediate Liquidity Ratio annovisbio.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Annovis Bio, Inc.
Attracting the neuroscience elite to combat Alzheimer's disease requires significant resources, which are accumulated within the balance sheet structure of Annovis Bio, Inc. (ANVS). The trend in total assets, derived reverse-engineered through ROA, demonstrates the aggregate value of assets and liabilities, allowing investors to assess the fundamental strength of Annovis Bio, Inc. (ANVS) and its capacity to sustain costly scientific research and development.
Main competitors
BIIB - Company Total Asset Base|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets vikingtherapeutics.com VKTX|SUPN - Aggregate Company Assets|Aggregate Asset Value CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aggregate Company Assets|Company Assets Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Company Total Assets|Company Total Assets amylyx.com|Aggregate Company Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Precision Medicines Inc - Total Business Assets|Aggregate Company Assets Anavex Corp AVXL|CBLL: Total Business Assets|PRTA - Aggregate Company Assets|Company Assets Alector, Inc.|ANNX (Annexon) - Cumulative Company Assets|OMER (Omeros) - Aggregate Company Assets|NGNE (Neurogene Corp) - Company Total Assets|AC Immune Inc (ACIU) - Company Total Asset Base|Aggregate Company Assets Voyager Therapeutics (VYGR)|Company Total Asset Base neumoratx.com|Scilex - Cumulative Company Assets|Aggregate Asset Value TVGN|Alpha Cognition Corp - Company Total Assets|CGTX: Aggregate Company Assets|IKT: Company Total Assets|SAVA - Company Total Asset Base|Aggregate Company Assets Assertio Holdings|Company Assets Coya COYA|Cumulative Company Assets VTGN (Vistagen Therapeutics)|OVID (ovidrx.com) - Aggregate Asset Value|Company Total Assets ABOS (Acumen Pharmaceuticals)|Company Total Asset Base cervomed.com (CRVO)|ATHE - Aggregate Company Assets|CLNN (Clene Inc.) - Total Business Assets|PEPG: Company Total Assets|Cumulative Company Assets Jupiter Neurosciences, Inc.|Cumulative Company Assets RLMD|Grace Tx (GRCE) - Company Total Asset Base|Company Total Assets AIFF|Company Total Assets anewmeds.com (KLTO)|Aggregate Company Assets NeuroSense Therapeutics Ltd. NRSN|RVPH: Total Business Assets|MTVA: Cumulative Company Assets|NRXS: Aggregate Company Assets|heliusmedical.com (HSDT) - Aggregate Company Assets|PASG - Company Total Asset Base|Aggregate Company Assets Neuphoria Therapeutics, Inc.|Total Business Assets NERV (Minerva)|Company Total Assets ATHA|ADXN - Company Assets|Alzamend Neuro - Cumulative Company Assets|Company Total Assets Cyclerion Therapeutics Inc. CYCN|PTIX - Aggregate Company Assets|Aggregate Asset Value KTTA (Pasithea Therapeutics)|cortigent.com (CRGT) - Aggregate Company Assets|Company Assets avenuetx.com (ATXI)|BCLI (BrainStorm Cell Therapeutics) - Company Total Assets|Company Total Assets Cara Therapeutics Inc.|Aggregate Company Assets Chromocell Therapeutics Corporation (CHRO)|eliemtx.com - Total Business Assets|Aggregate Company Assets Intra-Cellular Therapies, Inc. ITCI|LBPH: Total Business Assets|MRNS - Aggregate Company Assets|Company Assets NKGen Biotech Inc|NRBO (NeuroBo) - Cumulative Company Assets|SAGE (Sage Therapeutics Inc) - Aggregate Company Assets|SNPX (Synaptogenix, Inc.) - Company Total Assets|trevena.com (TRVN) - Company Total Asset Base|Aggregate Company Assets Vigil Neuroscience (VIGL)|Company Total Asset Base anewmeds.com|Cerevel - Cumulative Company Assets